Clinical Study
Urothelial Carcinoma of the Urinary Bladder in Young Adults: Presentation, Clinical behavior and Outcome
Table 1
Presentation, clinical characteristics, and treatment modalities of young patients with bladder cancer.
| Clinical characteristics of patients <40 years old treated for bladder cancer | | Age (yr) | | β€30 | 31β40 | Total | |
| Patients, (%) | 14 (45.16) | 17 (54,83) | 31 (100) | | Mean age (range), yr | 26,14 (21β30) | 37,29 (31β39) | | | Males/females | 9/5 | 10/7 | 19/12 | | Clinical characteristics at presentation | | | | | β(i) Macroscopic hematuria | 10 | 15 | 25 | | β (ii) UTIs | 1 | 1 | 2 | | β (iii) Microscopic hematuria | 3 | 1 | 4 | | Mean followup (range), mo | 39,36 | 37,68 | 38,52 | | Multifocality of bladder tumors (>2 lesions) | 4 | 6 | 10 | | Stage at presentation, | | | | | β (i) Ta | 10 | 13 | 23 | | β (ii) T1 | 4 | 1 | 5 | | β (iii) T2 | 0 | 2 | 2 | | β (iv) T3 | 0 | 1 | 1 | | β (v) T4 | 0 | 0 | 0 | | Grade at presentation, | | | | | β (i) Low (GI-II) | 14 | 15 | 29 | | β (ii) High (GIII) | 0 | 2 | 2 | | βRecurrence rate (%) | 4 (28) | 6 (35) | 10 (32) | | Intravesical therapy of superficial cancer (%) | 7/14 | 5/14 | 12/28 | | Cystectomy, (%) | 0 | 3 | 3 | | Adjuvant chemotherapy for invasive cancer, (%) | 0 | 2 | 2 | |
|
|